Market narrative
Move between stock news, official company releases, crypto, and FX without losing the path back to ticker research.
Shell PLC (LSE:SHEL, NYSE:SHEL) has struck a deal to sell its European onshore renewables business to France's TotalEnergies. The FTSE 100 oil giant said it was continuing to reshape its power portfolio and recycle capital into businesses where it believes it has a competitive advantage.
Stocks
Investment firm KKR has struck a deal to acquire medical-device outsourcing company Integer Holdings for about $4.3 billion in cash.
Featuring more visits to beloved ports, the season welcomes Nieuw Amsterdam back to Europe, bringing guests to the continent's iconic landmarks and seasonal experiences SEATTLE, Aug. 3, 2026 /PRNewswire/ -- Holland America Line has opened bookings for its 2028 Europe season, offering travelers more opportunities to explore the continent with expanded sailings across Northern Europe, the Mediterranean, the Canary Islands and beyond. Drawing on Holland America's more than 150 years of experience in the region, the new season combines iconic destinations with opportunities to connect more deeply with the cultures, landscapes and traditions that define them.
Increases Manufacturing Capacity for Long-Lead Material Doubles EU Supply Chain for Graphite Billet Production ROCKVILLE, Md., Aug. 03, 2026 (GLOBE NEWSWIRE) -- X-Energy, Inc. (Nasdaq: XE) (“X-energy” or “the Company”), a leading developer of advanced nuclear reactors and fuel technology, and SGL Carbon (“SGL”) today announced a binding agreement to double SGL's production capacity for medium-grain isotropic graphite (“NBG-18”), a specialized material central to X-energy's Xe-100 high-temperature gas-cooled reactor (“HTGR”).
Retirees heading into fall want two things from an income portfolio: a check that shows up every 30 days, and a dividend that will not be cut.
August is when institutional money quietly rotates. The Magnificent Seven trade is crowded, and the smart capital is moving one layer deeper into the AI stack: the fabricators, connectors, and power specialists that actually build the picks-and-shovels of the hyperscaler buildout.
Second quarter 2026 total global revenue of approximately $240 million, including BRIUMVI U.S. net product revenue of approximately $228 million Raises full year 2026 total global revenue target to approximately $950 million and raises full year 2026 BRIUMVI U.S. net product revenue target to approximately $890 - 905 million Conference call to be held today, Monday, August 3, 2026, at 8:30 AM ET NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the second quarter of 2026, along with recent company developments and provided an update on 2026 financial guidance. Michael S.
Phase 2 clinical study protocol submitted; Small Phase 2 study designed to support regulatory interactions and potential registration upon positive results Ramat Gan, Israel, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced the submission of a Phase 2 clinical study protocol to Bambino Gesù Children's Hospital in Rome, Italy, for the first clinical evaluation of Piclidenoson in patients with Lowe syndrome, a rare inherited genetic disorder with no approved disease-modifying therapies.
BRYN MAWR, Pa.--(BUSINESS WIRE)--Essential Utilities Inc. (NYSE: WTRG), one of the nation's largest publicly traded providers of water, wastewater and natural gas services, proudly recognizes Water Quality Month this August. Established by the U.S. Environmental Protection Agency in 2005, the annual observance highlights the vital importance of clean, safe water to public health, thriving communities and a sustainable environment. “Water is one of our planet's most vital natural resources, and.
HOUSTON--(BUSINESS WIRE)--Chevron Products Company, a division of Chevron U.S.A. Inc., will expand its North American base oils distribution network, strengthening customer access to premium base oils and process oils through complementary distribution agreements with HF Sinclair Lubricants & Specialties and Renkert Oil. Effective May 1, 2027, HF Sinclair Lubricants & Specialties will become Chevron's exclusive distributor of Group II base oils in Canada, and its existing customer terri.
Ocular's AXPAXLI TM wet AMD NDA submission on track for Q4 2026 following positive Type C Meeting with the U.S. FDA in May 2026
SGOV stands out as a conservative, principal-protected cash alternative amid market volatility. SGOV's negligible interest rate risk and monthly distributions align with rising benchmark rates, offering an attractive 3.8% yield. Current macro uncertainty, steepened yield curve, and expensive equities/REITs reinforce SGOV's appeal for nimble capital deployment.
First-in-class pan-RAS(ON) ADC is cleared for clinical development Designed to selectively deliver pan-RAS(ON) inhibition to tumors while minimizing systemic toxicity. IND submissions to U.S. FDA and China NMPA are in process SINGAPORE and NORTH BRUNSWICK, N.J.
Second Quarter 2026 Highlights Revenue increased 19% to €378 million Loss for the period of €4 million, 0.9% as a percentage of revenue with increased operating results offset by unrealized foreign currency losses Adjusted EBITDA1 increased 19% to €76 million and Adjusted EBITDA margin1 expanded to 20.2% Net cash from operating activities increased 20% to €117 million and Free cash flow1 increased 14% to €59 million Repurchased $140 million of shares during the quarter under the share repurchase plan Upsized revolving credit facility to €250 million, lowering fees and extending maturity to 2031 Entered into strategic partnerships with leading prediction market exchanges, expanding total addressable market ST. GALLEN, Switzerland, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Sportradar Group AG (Nasdaq: SRAD) (“Sportradar” or the “Company”), a leading global sports technology company focused on creating immersive experiences for sports fans and bettors, today announced financial results for its second quarter ended June 30, 2026.
Advisory Board to Direct Development of Military-Grade Technology as Eva Defense Leverages Eva Live's AI Technology — Step One in Building the Eva Defense Universe
COM701 MAIA-ovarian trial progressing as planned with median progression-free survival data from the interim analysis expected by Q1 2027 Trial-in-progress poster on MAIA-ovarian presented at the ESMO Gynaecological Cancers Congress 2026, reinforcing the biological and clinical rationale for evaluating COM701 in platinum-sensitive ovarian cancer Partner AstraZeneca presented new data at ASCO 2026, including the first overall survival readout from the GEMINI-Hepatobiliary study in first-line biliary tract cancer Gilead-partnered GS-0321 Phase 1 trial continues to progress as planned Solid financial position with cash runway expected to fund operations into 2029 HOLON, Israel, Aug. 3, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered by AI/ML, today reported financial results for the second quarter of 2026 and provided a corporate update.
New York, New York--(Newsfile Corp. - August 3, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Alignment Healthcare, Inc. ("Alignment Healthcare" or the "Company") (NASDAQ: ALHC). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are an Alignment Healthcare investor and have suffered losses, or if you have information that could assist in the Alignment Healthcare investigation, you may CLICK HERE to contact us.
Provident Financial Services remains a 'Hold' after strong Q2 results and a 25% stock gain over the past year. PFS benefits from robust loan growth, successful Lakeland integration, and expanding fee income but faces rising deposit costs and competitive funding pressures. Credit quality is solid with low charge-offs and manageable NPLs; reserve coverage appears sufficient even with senior housing exposure.
Longtime investor OPKO Health increases its position as Cocrystal advances toward norovirus Phase 1b data in late 2026 BOTHELL, Wash., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) ("Cocrystal" or the "Company"), a biotechnology company developing novel antiviral therapeutics, today announced a $5 million investment from OPKO Health, Inc. (Nasdaq: OPK) (“OPKO”), a longtime investor in the Company, has increased its position through a $5 million investment as the Company advances its lead norovirus program toward Phase 1b topline data later this year.
BAYONNE, N.J., Aug. 03, 2026 (GLOBE NEWSWIRE) -- BCB Bancorp, Inc. (the “Company”), (NASDAQ: BCBP), the holding company for BCB Community Bank (the “Bank”), today reported a net loss of $14.8 million for the second quarter of 2026, compared to net income of $4.9 million in the first quarter of 2026, and net income of $3.6 million for the second quarter of 2025. The Company's loss per diluted share for the second quarter was ($0.85) compared to earnings per diluted share of $0.26 in the preceding quarter and $0.18 in the second quarter of 2025. The Company's reported net loss for the six months ended June 30, 2026 was $9.9 million, compared to a net loss of $4.8 million for the six months ended June 30, 2025. The Company's loss per diluted share for the six months ended June 30, 2026 was ($0.60) compared to a loss per diluted share of ($0.33) for the six months ended June 30, 2025.
